Associated autoimmune diseases in systemic sclerosis define a subset of patients with milder disease: Results from 2 large cohorts of European Caucasian patients

Journal of Rheumatology

Volumn 37, Issue 3, 2010, Pages 608-614

  Avouac, Jérôme ^a   Airò, Paolo ^f   Dieude, Philippe ^a   Caramaschi, Paola ^g   Tiev, Kiet ^b   Diot, Elisabeth ^c   Sibilia, Jean ^d   Cappelli, Susanna ^h   Granel, Brigitte ^e   Vacca, Alessandra ⁱ   Wipff, Julien ^a   Meyer, Olivier ^a   Kahan, André ^a   Matucci Cerinic, Marco ^h   Allanore, Yannick ^a  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b HÔPITAL SAINT ANTOINE   (France)

^c CHU BRETONNEAU   (France)

^d UNIVERSITÉ DE STRASBOURG   (France)

^e North Hospital   (France)

^f Rheumatology and Immunology Unit   (Italy)

^g UNIVERSITY OF VERONA   (Italy)

^h UNIVERSITY OF FLORENCE   (Italy)

ⁱ UNIVERSITY OF CAGLIARI   (Italy)

Author keywords

Autoimmunity; Primary biliary cirrhosis; Sj gren's syndrome; Systemic sclerosis; Thyroiditis

Indexed keywords

ANTINUCLEAR ANTIBODY;

ADULT; ANTIBODY BLOOD LEVEL; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNE THYROIDITIS; CAUCASIAN; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE DURATION; DISEASE SEVERITY; FEMALE; HUMAN; LUNG FIBROSIS; MAJOR CLINICAL STUDY; MALE; MYOSITIS; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL; PROGNOSIS; RHEUMATOID ARTHRITIS; SJOEGREN SYNDROME; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS;

ADULT; AGED; ANTIBODIES, ANTINUCLEAR; AUTOIMMUNE DISEASES; COHORT STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FRANCE; HUMANS; ITALY; MIDDLE AGED; MULTIVARIATE ANALYSIS; PHENOTYPE; PREVALENCE; SCLERODERMA, SYSTEMIC; SEVERITY OF ILLNESS INDEX; SJOGREN'S SYNDROME; THYROIDITIS;

EID: 77949768088     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: 10.3899/jrheum.090815     Document Type: Article

References (30)

1. Allanore Y, Avouac J, Wipff J, Kahan A. New therapeutic strategies in the management of systemic sclerosis. Expert Opin Pharmacother 2007;8:607-15.
2. Harris ML, Rosen A. Autoimmunity in scleroderma: the origin, pathogenetic role, and clinical significance of autoantibodies. Curr Opin Rheumatol 2003;15:778-84.
3. Steen VD. Autoantibodies in systemic sclerosis. Semin Arthritis Rheum 2005;35:35-42.
4. Senecal JL, Henault J, Raymond Y. The pathogenic role of autoantibodies to nuclear autoantigens in systemic sclerosis (scleroderma). J Rheumatol 2005;32:1643-9.
5. Baroni SS, Santillo M, Bevilacqua F, Luchetti M, Spadoni T, Mancini M, et al. Stimulatory autoantibodies to the PDGF receptor in systemic sclerosis. N Engl J Med 2006;354:2667-76.
6. Caramaschi P, Biasi D, Volpe A, Carletto A, Cechetto M, Bambara LM, et al. Coexistence of systemic sclerosis with other autoimmune diseases. Rheumatol Int 2007;27:407-10.
7. Avouac J, Sordet C, Depinay C, Ardizonne M, Vacher-Lavenu MC, Sibilia J, et al. Systemic sclerosis-associated Sjögren's syndrome and relationship to the limited cutaneous subtype: results of a prospective study of sicca syndrome in 133 consecutive patients. Arthritis Rheum 2006;54:2243-9.
8. LeRoy EC, Black C, Fleischmajer R, Jablonska S, Krieg T, Medsger TA Jr, et al. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 1988;15:202-5.
9. Valentini G, Medsger TA Jr, Silman AJ, Bombardieri S. Conclusion and identification of the core set of variables to be used in clinical investigations. Clin Exp Rheumatol 2003;21(3 Suppl 29):S47-8.
10. Mukerjee D, St. George D, Coleiro B, Knight C, Denton CP, Davar J, et al. Prevalence and outcome in systemic sclerosis associated pulmonary arterial hypertension: application of a registry approach. Ann Rheum Dis 2003;62:1088-93.
11. Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE, et al. Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 2002;61:554-8.
12. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus [letter]. Arthritis Rheum 1997;40:1725.
13. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
14. Pearce EN, Farwell AP, Braverman LE. Thyroiditis. N Engl J Med 2003;348;2646-55.
15. Leuschner U. Primary biliary cirrhosis - presentation and diagnosis. Clin Liver Dis 2003;7:741-58.
16. Bohan A, Peter JB. Polymyositis and dermatomyositis (first of two parts). N Engl J Med 1975;292:344-7.
17. Bohan A, Peter JB. Polymyositis and dermatomyositis (second of two parts). N Engl J Med 1975;292:403-7.
18. Allanore Y, Meune C, Vonk MC, Airò P, Hachulla E, Caramaschi P, et al. Prevalence and factors associated with left ventricular dysfunction in the EULAR Scleroderma Trial and Research group (EUSTAR) database of systemic sclerosis patients. Ann Rheum Dis 2010;69:218-21.
19. Miyawaki S, Asanuma H, Nishiyama S, Yoshinaga Y. Clinical and serological heterogeneity in patients with anticentromere antibodies. J Rheumatol 2005;32:1488-94.
20. Walker UA, Tyndall A, Czirjak L, Denton CP, Farge-Bancel D, Kowal-Bielecka O, et al. Geographical variation of disease manifestations in systemic sclerosis: a report from the EULAR Scleroderma Trials and Research (EUSTAR) group database. Ann Rheum Dis 2009;68:856-62.
21. Binard A, Devauchelle-Pensec V, Fautrel B, Jousse S, Youinou P, Saraux A. Epidemiology of Sjögren's syndrome: where are we now? Clin Exp Rheumatol 2007;25:1-4.
22. Orgiazzi J. The spectrum of autoimmune thyroid diseases (AITD). Ann Med Interne 1999;150:294-300.
23. Dieude P, Guedj M, Wipff J, Avouac J, Hachulla J, Diot E, et al. The PTPN22 620W allele confers susceptibility to systemic sclerosis: findings of a large case-control study of European Caucasians and a meta-analysis. Arthritis Rheum 2008;58:2183-8.
24. Dunne J, Lynch S, O'Farrelly C, Todryk S, Hegarty JE, Feighery C, et al. Selective expansion and partial activation of human NK cells and NK receptor-positive T cells by IL-2 and IL-15. J Immunol 2001;167:3129-38.
25. Bonomo A, Kehn PJ, Payer E, Rizzo L, Cheever AW, Shevach EM. Pathogenesis of post-thymectomy autoimmunity. Role of syngeneic MLR-reactive T cells. J Immunol 1995;154:6602-11.
26. Allanore Y, Kahan A. Treatment of systemic sclerosis. Joint Bone Spine 2006;73:363-8.
27. Rodriguez-Reyna TS, Alarcon-Segovia D. The different faces of shared autoimmunity. Autoimmun Rev 2006;5:86-8.
28. Martinez A, Varade J, Marquez A, Cenit MC, Espino L, Perdigones N, et al. Association of the STAT4 gene with increased susceptibility for some immune-mediated diseases. Arthritis Rheum 2008;58:2598-602.
29. Dieude P, Guedj M, Wipff J, Avouac J, Fajardy I, Diot E, et al. Association between the IRF5 rs2004640 functional polymorphism and systemic sclerosis: a new perspective for pulmonary fibrosis. Arthritis Rheum 2009;60:225-33.
30. Anaya JM, Tobon GJ, Vega P, Castiblanco J. Autoimmune disease aggregation in families with primary Sjögren's syndrome. J Rheumatol 2006;33:2227-34.